查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
全球傳染病檢測分子診斷市場：北美繼續推動全球市場增長
市場調查報告書
商品編碼
1158552

全球傳染病檢測分子診斷市場：北美繼續推動全球市場增長

Market Study on Molecular Diagnostics in Infectious Disease Testing: North America to Continue Leading Global Market Growth
出版日期: | 出版商: Persistence Market Research | 英文 250 Pages | 商品交期: 2-5個工作天內

價格

本報告研究和分析了全球傳染病檢測分子診斷市場，提供了 2022-2032 年預測期的市場概況、趨勢、按細分市場和地區劃分的市場分析、競爭格局和公司概況，並提供了系統信息。

內容

第 1 章執行摘要

第 2 章市場概述

  • 市場範圍/分類
  • 市場定義/範圍/限制

第 3 章主要市場趨勢

  • 影響市場的主要趨勢
  • 傳染病檢測分子診斷行業的未來展望
    • 增長動力
    • 品牌湧入
    • 創新的分銷和營銷策略

第四章規章制度

第五章傳染病檢測分子診斷全球市場需求分析及預測

  • 過去的市場分析
  • 當前和未來的市場預測
  • 同比增長率趨勢分析

第 6 章全球傳染病檢測分子診斷市場：價格分析

  • 價格分析：按產品分類
  • 全球平均價格分析基準

第七章傳染病檢測分子診斷全球市場需求分析及預測

  • 過去的市場分析
  • 當前和未來的市場預測
    • 同比增長率趨勢分析

第八章市場背景

  • 宏觀經濟因素
    • GDP 增長前景
    • 個人消費前景
    • GDP 增長分析
    • 收入人群概覽
    • 人均可支配收入
  • 預測因素：相關性和影響
    • 主要公司的成長史
    • 城市化增長前景
    • 其他
  • 全球傳染病檢測分子診斷市場的 PESTLE 分析
  • 傳染病檢測分子診斷市場的投資可行性矩陣
  • 全球傳染病檢測分子診斷市場的波特五力分析
  • 市場動態
    • 司機
    • 約束因素
    • 機會分析

第 9 章傳染病檢測的全球分子診斷市場分析和預測：按產品分類

  • 簡介/主要發現
  • 過去的市場分析：按產品分類
  • 當前和未來的市場分析和預測：按產品
    • 儀器和分析儀
    • 化驗和試劑
    • 服務和軟件
  • 市場吸引力分析：按產品

第 10 章傳染病檢測的全球分子診斷市場分析和預測：按應用

  • 簡介/主要發現
  • 過去的市場分析：按應用
  • 當前和未來的市場分析和預測：按應用
    • 乙型肝炎
    • 丙型肝炎
    • 艾滋病
    • 肺結核
    • 耐甲氧西林金黃色葡萄球菌 (MRSA)
    • 院內感染
    • 沙眼衣原體和淋病奈瑟菌 (CT/NG)
    • 人乳頭瘤病毒 (HPV) 感染
    • 其他
  • 市場吸引力分析：按應用

第 11 章全球傳染病檢測分子診斷市場分析和預測：按技術分類

  • 簡介/主要發現
  • 歷史市場和分析：按技術分類
  • 當前和未來的市場分析和預測：按技術分類
    • 聚合□鍊式反應 (PCR)
    • 等溫核酸擴增技術 (INAAT)
    • 微陣列
    • 下一代測序 (NGS)
    • 雜交
    • 其他
  • 市場吸引力分析：按技術

第 12 章傳染病檢測的全球分子診斷市場分析和預測：最終用戶

  • 簡介/主要發現
  • 過去的市場分析：按最終用戶
  • 當前和未來的市場分析和預測：按最終用戶分類
    • 醫院
    • 私人實驗室
    • 診所
    • 學術機構
    • 實驗室
    • 其他
  • 市場吸引力分析：按最終用戶

第 13 章全球傳染病檢測分子診斷市場分析和預測：按地區

  • 介紹
  • 過去的市場分析：按地區
  • 當前市場分析和預測：按地區
    • 北美
    • 拉丁美洲
    • 歐洲
    • 東亞
    • 南亞
    • 大洋洲
    • 中東和非洲 (MEA)
  • 市場吸引力分析：按地區

第十四章北美傳染病檢測分子診斷市場分析及預測

  • 介紹
  • 價格分析
  • 過去的市場和交易量趨勢分析：按市場分類
  • 市場和數量預測：按市場分類
    • 按國家
    • 按產品分類
    • 最終用戶
    • 通過使用
    • 按技術
  • 市場吸引力分析
    • 按國家
    • 按產品分類
    • 最終用戶
    • 通過使用
    • 按技術

第 15 章拉丁美洲傳染病檢測分子診斷市場分析與預測

  • 介紹
  • 價格分析
  • 過去的市場和交易量趨勢分析：按市場分類
  • 市場和數量預測：按市場分類
    • 按國家
    • 按產品分類
    • 最終用戶
    • 通過使用
    • 按技術
  • 市場吸引力分析
    • 按國家
    • 按產品分類
    • 最終用戶
    • 通過使用
    • 按技術

第十六章歐洲傳染病檢測分子診斷市場分析及預測

  • 介紹
  • 價格分析
  • 過去的市場和交易量趨勢分析：按市場分類
  • 市場和數量預測：按市場分類
    • 按國家
    • 按產品分類
    • 最終用戶
    • 通過使用
    • 按技術
  • 市場吸引力分析
    • 按國家
    • 按產品分類
    • 最終用戶
    • 通過使用
    • 按技術

第十七章南亞傳染病檢測分子診斷市場分析及預測

  • 介紹
  • 價格分析
  • 過去的市場和交易量趨勢分析：按市場分類
  • 市場和數量預測：按市場分類
    • 按國家
    • 按產品分類
    • 最終用戶
    • 通過使用
    • 按技術
  • 市場吸引力分析
    • 按國家
    • 按產品分類
    • 最終用戶
    • 通過使用
    • 按技術

第十八章東亞地區傳染病檢測分子診斷市場分析及預測

  • 介紹
  • 價格分析
  • 過去的市場和交易量趨勢分析：按市場分類
  • 市場和數量預測：按市場分類
    • 按國家
    • 按產品分類
    • 最終用戶
    • 通過使用
    • 按技術
  • 市場吸引力分析
    • 按國家
    • 按產品分類
    • 最終用戶
    • 通過使用
    • 按技術

第十九章大洋洲傳染病檢測分子診斷市場分析及預測

  • 介紹
  • 價格分析
  • 過去的市場和交易量趨勢分析：按市場分類
  • 市場和數量預測：按市場分類
    • 按國家
    • 按產品分類
    • 最終用戶
    • 通過使用
    • 按技術
  • 市場吸引力分析
    • 按國家
    • 按產品分類
    • 最終用戶
    • 通過使用
    • 按技術

第 20 章中東和非洲傳染病檢測分子診斷市場分析與預測

  • 介紹
  • 價格分析
  • 過去的市場和交易量趨勢分析：按市場分類
  • 市場和數量預測：按市場分類
    • 按國家
    • 按產品分類
    • 最終用戶
    • 通過使用
    • 按技術
  • 市場吸引力分析
    • 按國家
    • 按產品分類
    • 最終用戶
    • 通過使用
    • 按技術

第21章主要國家傳染病檢測分子診斷市場分析

  • 介紹
    • 市值比率分析：主要國家
    • 全球和國家增長比較
  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 德國
  • 意大利
  • 英國
  • 中國
  • 日本
  • 韓國
  • 印度
  • 澳大利亞和新西蘭
  • 南非

第22章市場結構分析

  • 市場分析：公司分層（傳染病檢測的分子診斷）
  • 市場集中度
  • 主要公司的市場份額分析
  • 市場佔有率分析
    • 按公司地理分佈
    • 產品足跡：按公司分類
    • 渠道足跡：按公司分類

第23章競爭分析

  • 比賽儀表板
  • 價格分析：按競爭對手
  • 競爭基準
  • 衝突詳情
    • Abbott Laboratories
    • Becton
    • Dickinson and Company
    • bioMerieux
    • Thermo Fisher Scientific Inc.
    • F. Hoffmann-La Roche Ltd
    • Siemens AG
    • Veridex, LLC
    • Luminex Corp.
    • GenMark Diagnostics, Inc.
    • Qiagen N.V.
    • Genomix Biotech
    • bioTheranostics

第 24 章先決條件和使用的首字母縮略詞

第 25 章研究方法論

Product Code: PMRREP4427

Report Scope:

Persistence Market Research recently published a new report on the molecular diagnostics in infectious disease testing market for the assessment period of 2022-2032. The report offers a close look at the evolving aspects of the market, and insights into the dynamics impacting market growth. It also focuses on key developments in the market, especially due to the COVID-19 pandemic situation that has affected people, globally. The report includes various macro- and micro-economic factors responsible for a significant impact on market growth.

The report on the molecular diagnostics in infectious disease testing market extensively focuses on the key trends shaping its growth. Additionally, the included opportunity analysis underlines untapped corners for aspiring players. The report also offers a holistic view of the incremental opportunity, which can further help readers make effective decisions for the growth of their businesses.

All stakeholders in the molecular diagnostics in infectious disease testing market can rely on the data offered in this report to make critical decisions. Moreover, the information offered in this report also can help new market entrants expand their bases in this space.

The report elaborates on both, historical and current trends shaping the molecular diagnostics in infectious disease testing market. The performance journey of the market has been drawn and analyzed to make the lucrative opportunities in the market evident to readers. The competitive landscape presented in the report gives a detailed outlook of the profiles of key companies manufacturing molecular diagnostics in infectious disease testing, along with their differential strategies and key focus areas.

Segmentation

The research study offers a detailed market taxonomy, wherein, key segments have been discussed in detail. The market is segmented on the basis of product, application, technique, end user, and region. Every segment is analyzed in detail, and data pertaining to the growth of each segment has been included in the study.

Product

  • Instruments and Analyzers
  • Assays and Reagents
  • Services and Software

Application

  • Hepatitis B
  • Hepatitis C
  • AIDS
  • Tuberculosis
  • Methicillin-Resistant Staphylococcus Aureus (MRSA)
  • Hospital-Acquired Infections
  • Chlamydia Trachomatis and Neisseria Gonorrhoeae (CT/NG)
  • Human Papillomavirus (HPV) Infection
  • Others

Technique

  • Polymerase Chain Reaction (PCR)
  • Isothermal Nucleic Acid Amplification Technology (INAAT)
  • Microarrays
  • Next-Generation Sequencing (NGS)
  • Hybridization
  • Others

End User

  • Hospitals
  • Private Labs
  • Clinics
  • Academic Institutes
  • Laboratories
  • Others

Region

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • Middle East & Africa

The research report includes a competitive landscape that provides a dashboard view of the key competitors operating in the market. Some of the market players included in this section are Abbott Laboratories, Becton, Dickinson and Company, bioMerieux, Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd, Siemens AG, Veridex, LLC, Luminex Corp., GenMark Diagnostics, Inc., Qiagen N.V., Genomix Biotech, and bioTheranostics.

Key Questions Answered in Report

The research study on the manufacturing molecular diagnostics in infectious disease testing market offers inclusive insights about the growth of the market in the most comprehensive manner. Key insights offered in the report answer some of the most salient questions that assist stakeholders in gauging all the emerging possibilities.

  • Will the polymerase chain reaction (PCR) segment continue driving the sales of molecular diagnostics in infectious disease testing market?
  • How are technological developments aiding molecular diagnostics in infectious disease testing market?
  • Which region is a key contributor to the global molecular diagnostics in infectious disease testing market?

Research Methodology

A unique and promising research methodology forms the base of the market report for the forecast period. This report has been prepared after comprehensive analysis of market events, and riveting insights have been compiled meticulously.

The research methodology is a two-step process comprising primary and secondary research. Key stakeholders, including suppliers, service providers, and experts of several designations, including executive vice presidents, directors, technical advisors, GM marketing professionals, and sales professionals have been interviewed. Secondary sources referred to obtain information include investor presentations of manufacturers, World Bank, IMF, and other credible sources.

Table of Contents

1. Executive Summary

  • 1.1. Global Market Overview
  • 1.2. Summary of Key Statistics
  • 1.3. Summary of Key Findings
  • 1.4. Product Evolution Analysis
  • 1.5. PMR Analysis and Recommendations

2. Market Overview

  • 2.1. Market Coverage/Taxonomy
  • 2.2. Market Definition/Scope/Limitations

3. Key Market Trends

  • 3.1. Key Trends Impacting the Market
  • 3.2. Future Prospects of Molecular Diagnostics in Infectious Disease Testing Industry
    • 3.2.1. Factors Fuelling Growth
    • 3.2.2. Influx of Brands
    • 3.2.3. Innovative Distribution & Marketing Strategies

4. Rules and Regulations

  • 4.1. Warning Labels
  • 4.2. Regulatory Options for Little Cigars
    • 4.2.1. Product Description
    • 4.2.2. Health Risks
    • 4.2.3. End Usering
    • 4.2.4. Minimum Pack Technique Regulatory Gap
  • 4.3. Cigar Labeling and Warning Statement Requirements by FDA
  • 4.4. Tobacco Control Laws
    • 4.4.1. Use of E-Cigarettes is Prohibited
    • 4.4.2. Tobacco Advertising is Prohibited in Mass Media
    • 4.4.3. Others
  • 4.5. Others (During the Course of Study)

5. Global Molecular Diagnostics in Infectious Disease Testing Market Demand Analysis 2017-2021 and Forecast, 2022-2032

  • 5.1. Historical Market Volume ('000 Units) Analysis, 2017-2021
  • 5.2. Current and Future Market Volume ('000 Units) Projections, 2022-2032
  • 5.3. Y-o-Y Growth Trend Analysis

6. Global Molecular Diagnostics in Infectious Disease Testing Market - Pricing Analysis

  • 6.1. Pricing Analysis By Product
  • 6.2. Global Average Pricing Analysis Benchmark

7. Global Molecular Diagnostics in Infectious Disease Testing Market Demand (in Value or Technique in US$ Mn) Analysis 2017-2021 and Forecast, 2022-2032

  • 7.1. Historical Market Value (US$ Mn) Analysis, 2017-2021
  • 7.2. Current and Future Market Value (US$ Mn) Projections, 2022-2032
    • 7.2.1. Y-o-Y Growth Trend Analysis
    • 7.2.2. Absolute $ Opportunity Analysis

8. Market Background

  • 8.1. Global Cigar industry Outlook
    • 8.1.1. Perception of Cigars
    • 8.1.2. Prevalence of Smoking Cigars among Adults
    • 8.1.3. Top 10 Cigars & Cigarillo Companies in the World
  • 8.2. Macro-Economic Factors
    • 8.2.1. GDP Growth Outlook
    • 8.2.2. Consumer Spending Outlook
    • 8.2.3. GDP Growth Rate Analysis
    • 8.2.4. Income Group Population Overview
    • 8.2.5. Per Capita Disposable Income
  • 8.3. Forecast Factors - Relevance & Impact
    • 8.3.1. Top Companies Historical Growth
    • 8.3.2. Urbanization Growth Outlook
    • 8.3.3. Others
  • 8.4. PESTLE Analysis of Global Molecular Diagnostics in Infectious Disease Testing Market
  • 8.5. Investment Feasibility Matrix of Molecular Diagnostics in Infectious Disease Testing Market
  • 8.6. Porter's Five Forces Analysis of Global Molecular Diagnostics in Infectious Disease Testing Market
  • 8.7. Market Dynamics
    • 8.7.1. Drivers
    • 8.7.2. Restraints
    • 8.7.3. Opportunity Analysis

9. Global Molecular Diagnostics in Infectious Disease Testing Market Analysis 2017-2021 and Forecast 2022-2032, By Product

  • 9.1. Introduction / Key Findings
  • 9.2. Historical Market Size (US$ Mn) and Volume ('000 Units) Analysis by Product, 2017 - 2021
  • 9.3. Current and Future Market Size (US$ Mn) and Volume ('000 Units) Analysis and Forecast by Product, 2022 - 2032
    • 9.3.1. Instruments and Analyzers
    • 9.3.2. Assays and Reagents
    • 9.3.3. Services and Software
  • 9.4. Market Attractiveness Analysis by Product

10. Global Molecular Diagnostics in Infectious Disease Testing Market Analysis 2017-2021 and Forecast 2022-2032, by Application

  • 10.1. Introduction / Key Findings
  • 10.2. Historical Market Size (US$ Mn) and Volume ('000 Units) Analysis by Application, 2017 - 2021
  • 10.3. Current and Future Market Size (US$ Mn) and Volume ('000 Units) Analysis and Forecast by Application, 2022 - 2032
    • 10.3.1. Hepatitis B
    • 10.3.2. Hepatitis C
    • 10.3.3. AIDS
    • 10.3.4. Tuberculosis
    • 10.3.5. Methicillin-Resistant Staphylococcus Aureus (MRSA)
    • 10.3.6. Hospital-Acquired Infections
    • 10.3.7. Chlamydia Trachomatis and Neisseria Gonorrhoeae (CT/NG)
    • 10.3.8. Human Papillomavirus (HPV) Infection
    • 10.3.9. Others
  • 10.4. Market Attractiveness Analysis by Application

11. Global Molecular Diagnostics in Infectious Disease Testing Market Analysis 2017-2021 and Forecast 2022-2032, by Technique

  • 11.1. Introduction / Key Findings
  • 11.2. Historical Market Size (US$ Mn) and Volume ('000 Units) Analysis by Technique, 2017 - 2021
  • 11.3. Current and Future Market Size (US$ Mn) and Volume ('000 Units) Analysis and Forecast by Technique, 2022 - 2032
    • 11.3.1. Polymerase Chain Reaction (PCR)
    • 11.3.2. Isothermal Nucleic Acid Amplification Technology (INAAT)
    • 11.3.3. Microarrays
    • 11.3.4. Next-Generation Sequencing (NGS)
    • 11.3.5. Hybridization
    • 11.3.6. Others
  • 11.4. Market Attractiveness Analysis by Technique

12. Global Molecular Diagnostics in Infectious Disease Testing Market Analysis 2017-2021 and Forecast 2022-2032, by End User

  • 12.1. Introduction / Key Findings
  • 12.2. Historical Market Size (US$ Mn) and Volume ('000 Units) Analysis by Flavor, 2017 - 2021
  • 12.3. Current and Future Market Size (US$ Mn) and Volume ('000 Units) Analysis and Forecast by Flavor, 2022 - 2032
    • 12.3.1. Hospitals
    • 12.3.2. Private Labs
    • 12.3.3. Clinics
    • 12.3.4. Academic Institutes
    • 12.3.5. Laboratories
    • 12.3.6. Others
  • 12.4. Market Attractiveness Analysis by Flavor

13. Global Molecular Diagnostics in Infectious Disease Testing Market Analysis 2017-2021 and Forecast 2022-2032, by Region

  • 13.1. Introduction
  • 13.2. Historical Market Size (US$ Mn) and Volume ('000 Units) Analysis by Region, 2017 - 2021
  • 13.3. Current Market Size (US$ Mn) and Volume ('000 Units) Analysis and Forecast by Region, 2022 - 2032
    • 13.3.1. North America
    • 13.3.2. Latin America
    • 13.3.3. Europe
    • 13.3.4. East Asia
    • 13.3.5. South Asia
    • 13.3.6. Oceania
    • 13.3.7. Middle East and Africa (MEA)
  • 13.4. Market Attractiveness Analysis by Region

14. North America Molecular Diagnostics in Infectious Disease Testing Market Analysis 2017-2021 and Forecast 2022-2032

  • 14.1. Introduction
  • 14.2. Pricing Analysis
  • 14.3. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2017 - 2021
  • 14.4. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2022 - 2032
    • 14.4.1. By Country
      • 14.4.1.1. U.S.
      • 14.4.1.2. Canada
    • 14.4.2. By Product
    • 14.4.3. By End User
    • 14.4.4. By Application
    • 14.4.5. By Technique
  • 14.5. Market Attractiveness Analysis
    • 14.5.1. By Country
    • 14.5.2. By Product
    • 14.5.3. By End User
    • 14.5.4. By Application
    • 14.5.5. By Technique

15. Latin America Molecular Diagnostics in Infectious Disease Testing Market Analysis 2017-2021 and Forecast 2022-2032

  • 15.1. Introduction
  • 15.2. Pricing Analysis
  • 15.3. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2017 - 2021
  • 15.4. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2022 - 2032
    • 15.4.1. By Country
      • 15.4.1.1. Brazil
      • 15.4.1.2. Mexico
      • 15.4.1.3. Rest of Latin America
    • 15.4.2. By Product
    • 15.4.3. By End User
    • 15.4.4. By Application
    • 15.4.5. By Technique
  • 15.5. Market Attractiveness Analysis
    • 15.5.1. By Country
    • 15.5.2. By Product
    • 15.5.3. By End User
    • 15.5.4. By Application
    • 15.5.5. By Technique

16. Europe Molecular Diagnostics in Infectious Disease Testing Market Analysis 2017-2021 and Forecast 2022-2032

  • 16.1. Introduction
  • 16.2. Pricing Analysis
  • 16.3. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2017 - 2021
  • 16.4. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2022 - 2032
    • 16.4.1. By Country
      • 16.4.1.1. Germany
      • 16.4.1.2. Italy
      • 16.4.1.3. France
      • 16.4.1.4. U.K.
      • 16.4.1.5. Spain
      • 16.4.1.6. Rest of Europe
    • 16.4.2. By Product
    • 16.4.3. By End User
    • 16.4.4. By Application
    • 16.4.5. By Technique
  • 16.5. Market Attractiveness Analysis
    • 16.5.1. By Country
    • 16.5.2. By Product
    • 16.5.3. By End User
    • 16.5.4. By Application
    • 16.5.5. By Technique

17. South Asia Molecular Diagnostics in Infectious Disease Testing Market Analysis 2017-2021 and Forecast 2022-2032

  • 17.1. Introduction
  • 17.2. Pricing Analysis
  • 17.3. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2017 - 2021
  • 17.4. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2022 - 2032
    • 17.4.1. By Country
      • 17.4.1.1. India
      • 17.4.1.2. Thailand
      • 17.4.1.3. Indonesia
      • 17.4.1.4. Malaysia
      • 17.4.1.5. Rest of South Asia
    • 17.4.2. By Product
    • 17.4.3. By End User
    • 17.4.4. By Application
    • 17.4.5. By Technique
  • 17.5. Market Attractiveness Analysis
    • 17.5.1. By Country
    • 17.5.2. By Product
    • 17.5.3. By End User
    • 17.5.4. By Application
    • 17.5.5. By Technique

18. East Asia Molecular Diagnostics in Infectious Disease Testing Market Analysis 2017-2021 and Forecast 2022-2032

  • 18.1. Introduction
  • 18.2. Pricing Analysis
  • 18.3. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2017 - 2021
  • 18.4. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2022 - 2032
    • 18.4.1. By Country
      • 18.4.1.1. China
      • 18.4.1.2. Japan
      • 18.4.1.3. South Korea
    • 18.4.2. By Product
    • 18.4.3. By End User
    • 18.4.4. By Application
    • 18.4.5. By Technique
  • 18.5. Market Attractiveness Analysis
    • 18.5.1. By Country
    • 18.5.2. By Product
    • 18.5.3. By End User
    • 18.5.4. By Application
    • 18.5.5. By Technique

19. Oceania Molecular Diagnostics in Infectious Disease Testing Market Analysis 2017-2021 and Forecast 2022-2032

  • 19.1. Introduction
  • 19.2. Pricing Analysis
  • 19.3. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2017 - 2021
  • 19.4. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2022 - 2032
    • 19.4.1. By Country
      • 19.4.1.1. Australia
      • 19.4.1.2. New Zealand
    • 19.4.2. By Product
    • 19.4.3. By End User
    • 19.4.4. By Application
    • 19.4.5. By Technique
  • 19.5. Market Attractiveness Analysis
    • 19.5.1. By Country
    • 19.5.2. By Product
    • 19.5.3. By End User
    • 19.5.4. By Application
    • 19.5.5. By Technique

20. Middle East and Africa Molecular Diagnostics in Infectious Disease Testing Market Analysis 2017-2021 and Forecast 2022-2032

  • 20.1. Introduction
  • 20.2. Pricing Analysis
  • 20.3. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2017 - 2021
  • 20.4. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2022 - 2032
    • 20.4.1. By Country
      • 20.4.1.1. GCC Countries
      • 20.4.1.2. Northern Africa
      • 20.4.1.3. South Africa
      • 20.4.1.4. Rest of Middle East and Africa
    • 20.4.2. By Product
    • 20.4.3. By End User
    • 20.4.4. By Application
    • 20.4.5. By Technique
  • 20.5. Market Attractiveness Analysis
    • 20.5.1. By Country
    • 20.5.2. By Product
    • 20.5.3. By End User
    • 20.5.4. By Application
    • 20.5.5. By Technique

21. Key Countries' Molecular Diagnostics in Infectious Disease Testing Market Analysis 2022-2032

  • 21.1. Introduction
    • 21.1.1. Market Value Proportion Analysis, By Key Countries
    • 21.1.2. Global Vs. Country Growth Comparison
  • 21.2. U.S. Molecular Diagnostics in Infectious Disease Testing Market Analysis
    • 21.2.1. By Product
    • 21.2.2. By End User
    • 21.2.3. By Application
    • 21.2.4. By Technique
  • 21.3. Canada Molecular Diagnostics in Infectious Disease Testing Market Analysis
    • 21.3.1. By Product
    • 21.3.2. By End User
    • 21.3.3. By Application
    • 21.3.4. By Technique
  • 21.4. Mexico Molecular Diagnostics in Infectious Disease Testing Market Analysis
    • 21.4.1. By Product
    • 21.4.2. By End User
    • 21.4.3. By Application
    • 21.4.4. By Technique
  • 21.5. Brazil Molecular Diagnostics in Infectious Disease Testing Market Analysis
    • 21.5.1. By Product
    • 21.5.2. By End User
    • 21.5.3. By Application
    • 21.5.4. By Technique
  • 21.6. Germany Molecular Diagnostics in Infectious Disease Testing Market Analysis
    • 21.6.1. By Product
    • 21.6.2. By End User
    • 21.6.3. By Application
    • 21.6.4. By Technique
  • 21.7. Italy Molecular Diagnostics in Infectious Disease Testing Market Analysis
    • 21.7.1. By Product
    • 21.7.2. By End User
    • 21.7.3. By Application
    • 21.7.4. By Technique
  • 21.8. U.K. Molecular Diagnostics in Infectious Disease Testing Market Analysis
    • 21.8.1. By Product
    • 21.8.2. By End User
    • 21.8.3. By Application
    • 21.8.4. By Technique
  • 21.9. China Molecular Diagnostics in Infectious Disease Testing Market Analysis
    • 21.9.1. By Product
    • 21.9.2. By End User
    • 21.9.3. By Application
    • 21.9.4. By Technique
  • 21.10. Japan Molecular Diagnostics in Infectious Disease Testing Market Analysis
    • 21.10.1. By Product
    • 21.10.2. By End User
    • 21.10.3. By Application
    • 21.10.4. By Technique
  • 21.11. S. Korea Molecular Diagnostics in Infectious Disease Testing Market Analysis
    • 21.11.1. By Product
    • 21.11.2. By End User
    • 21.11.3. By Application
    • 21.11.4. By Technique
  • 21.12. India Molecular Diagnostics in Infectious Disease Testing Market Analysis
    • 21.12.1. By Product
    • 21.12.2. By End User
    • 21.12.3. By Application
    • 21.12.4. By Technique
  • 21.13. Australia and New Zealand Molecular Diagnostics in Infectious Disease Testing Market Analysis
    • 21.13.1. By Product
    • 21.13.2. By End User
    • 21.13.3. By Application
    • 21.13.4. By Technique
  • 21.14. South Africa Molecular Diagnostics in Infectious Disease Testing Market Analysis
    • 21.14.1. By Product
    • 21.14.2. By End User
    • 21.14.3. By Application
    • 21.14.4. By Technique

22. Market Structure Analysis

  • 22.1. Market Analysis by Tier of Companies (Molecular Diagnostics in Infectious Disease Testing)
  • 22.2. Market Concentration
  • 22.3. Market Share Analysis of Top Players
  • 22.4. Market Presence Analysis
    • 22.4.1. By Regional footprint of Players
    • 22.4.2. Product foot print by Players
    • 22.4.3. Channel Foot Print by Players

23. Competition Analysis

  • 23.1. Competition Dashboard
  • 23.2. Pricing Analysis by Competition
  • 23.3. Competition Benchmarking
  • 23.4. Competition Deep Dive
    • 23.4.1. Abbott Laboratories
      • 23.4.1.1. Overview
      • 23.4.1.2. Product Portfolio
      • 23.4.1.3. Profitability by Market Segments (Product/Channel/Region)
      • 23.4.1.4. Sales Footprint
      • 23.4.1.5. Strategy Overview
        • 23.4.1.5.1. Marketing Strategy
        • 23.4.1.5.2. Product Strategy
        • 23.4.1.5.3. Channel Strategy
    • 23.4.2. Becton
      • 23.4.2.1. Overview
      • 23.4.2.2. Product Portfolio
      • 23.4.2.3. Profitability by Market Segments (Product/Channel/Region)
      • 23.4.2.4. Sales Footprint
      • 23.4.2.5. Strategy Overview
        • 23.4.2.5.1. Marketing Strategy
        • 23.4.2.5.2. Product Strategy
        • 23.4.2.5.3. Channel Strategy
    • 23.4.3. Dickinson and Company
      • 23.4.3.1. Overview
      • 23.4.3.2. Product Portfolio
      • 23.4.3.3. Profitability by Market Segments (Product/Channel/Region)
      • 23.4.3.4. Sales Footprint
      • 23.4.3.5. Strategy Overview
        • 23.4.3.5.1. Marketing Strategy
        • 23.4.3.5.2. Product Strategy
        • 23.4.3.5.3. Channel Strategy
    • 23.4.4. bioMerieux
      • 23.4.4.1. Overview
      • 23.4.4.2. Product Portfolio
      • 23.4.4.3. Profitability by Market Segments (Product/Channel/Region)
      • 23.4.4.4. Sales Footprint
      • 23.4.4.5. Strategy Overview
        • 23.4.4.5.1. Marketing Strategy
        • 23.4.4.5.2. Product Strategy
        • 23.4.4.5.3. Channel Strategy
    • 23.4.5. Thermo Fisher Scientific Inc.
      • 23.4.5.1. Overview
      • 23.4.5.2. Product Portfolio
      • 23.4.5.3. Profitability by Market Segments (Product/Channel/Region)
      • 23.4.5.4. Sales Footprint
      • 23.4.5.5. Strategy Overview
        • 23.4.5.5.1. Marketing Strategy
        • 23.4.5.5.2. Product Strategy
        • 23.4.5.5.3. Channel Strategy
    • 23.4.6. F. Hoffmann-La Roche Ltd
      • 23.4.6.1. Overview
      • 23.4.6.2. Product Portfolio
      • 23.4.6.3. Profitability by Market Segments (Product/Channel/Region)
      • 23.4.6.4. Sales Footprint
      • 23.4.6.5. Strategy Overview
        • 23.4.6.5.1. Marketing Strategy
        • 23.4.6.5.2. Product Strategy
        • 23.4.6.5.3. Channel Strategy
    • 23.4.7. Siemens AG
      • 23.4.7.1. Overview
      • 23.4.7.2. Product Portfolio
      • 23.4.7.3. Profitability by Market Segments (Product/Channel/Region)
      • 23.4.7.4. Sales Footprint
      • 23.4.7.5. Strategy Overview
        • 23.4.7.5.1. Marketing Strategy
        • 23.4.7.5.2. Product Strategy
        • 23.4.7.5.3. Channel Strategy
    • 23.4.8. Veridex, LLC
      • 23.4.8.1. Overview
      • 23.4.8.2. Product Portfolio
      • 23.4.8.3. Profitability by Market Segments (Product/Channel/Region)
      • 23.4.8.4. Sales Footprint
      • 23.4.8.5. Strategy Overview
        • 23.4.8.5.1. Marketing Strategy
        • 23.4.8.5.2. Product Strategy
        • 23.4.8.5.3. Channel Strategy
    • 23.4.9. Luminex Corp.
      • 23.4.9.1. Overview
      • 23.4.9.2. Product Portfolio
      • 23.4.9.3. Profitability by Market Segments (Product/Channel/Region)
      • 23.4.9.4. Sales Footprint
      • 23.4.9.5. Strategy Overview
        • 23.4.9.5.1. Marketing Strategy
        • 23.4.9.5.2. Product Strategy
        • 23.4.9.5.3. Channel Strategy
    • 23.4.10. GenMark Diagnostics, Inc.
      • 23.4.10.1. Overview
      • 23.4.10.2. Product Portfolio
      • 23.4.10.3. Profitability by Market Segments (Product/Channel/Region)
      • 23.4.10.4. Sales Footprint
      • 23.4.10.5. Strategy Overview
        • 23.4.10.5.1. Marketing Strategy
        • 23.4.10.5.2. Product Strategy
        • 23.4.10.5.3. Channel Strategy
    • 23.4.11. Qiagen N.V.
      • 23.4.11.1. Overview
      • 23.4.11.2. Product Portfolio
      • 23.4.11.3. Profitability by Market Segments (Product/Channel/Region)
      • 23.4.11.4. Sales Footprint
      • 23.4.11.5. Strategy Overview
        • 23.4.11.5.1. Marketing Strategy
        • 23.4.11.5.2. Product Strategy
        • 23.4.11.5.3. Channel Strategy
    • 23.4.12. Genomix Biotech
      • 23.4.12.1. Overview
      • 23.4.12.2. Product Portfolio
      • 23.4.12.3. Profitability by Market Segments (Product/Channel/Region)
      • 23.4.12.4. Sales Footprint
      • 23.4.12.5. Strategy Overview
        • 23.4.12.5.1. Marketing Strategy
        • 23.4.12.5.2. Product Strategy
        • 23.4.12.5.3. Channel Strategy
    • 23.4.13. bioTheranostics
      • 23.4.13.1. Overview
      • 23.4.13.2. Product Portfolio
      • 23.4.13.3. Profitability by Market Segments (Product/Channel/Region)
      • 23.4.13.4. Sales Footprint
      • 23.4.13.5. Strategy Overview
        • 23.4.13.5.1. Marketing Strategy
        • 23.4.13.5.2. Product Strategy
        • 23.4.13.5.3. Channel Strategy

24. Assumptions and Acronyms Used

25. Research Methodology

List of Tables

  • Table 1: Global Molecular Diagnostics in Infectious Disease Testing Market Value (US$ Mn) Forecast, By Product, 2017-2032
  • Table 2: Global Molecular Diagnostics in Infectious Disease Testing Market Volume ('000 Units) Forecast, By Product, 2017-2032
  • Table 3: Global Molecular Diagnostics in Infectious Disease Testing Market Value (US$ Mn) Forecast, By End User, 2017-2032
  • Table 4: Global Molecular Diagnostics in Infectious Disease Testing Market Volume ('000 Units) Forecast, By End User, 2017-2032
  • Table 5: Global Molecular Diagnostics in Infectious Disease Testing Market Value (US$ Mn) Forecast, By Application, 2017-2032
  • Table 6: Global Molecular Diagnostics in Infectious Disease Testing Market Volume ('000 Units) Forecast, By Application, 2017-2032
  • Table 7: Global Molecular Diagnostics in Infectious Disease Testing Market Value (US$ Mn) Forecast, By Technique, 2017-2032
  • Table 8: Global Molecular Diagnostics in Infectious Disease Testing Market Volume ('000 Units) Forecast, By Technique, 2017-2032
  • Table 9: Global Molecular Diagnostics in Infectious Disease Testing Market Value (US$ Mn) Forecast, By Region, 2017-2032
  • Table 10: Global Molecular Diagnostics in Infectious Disease Testing Market Volume ('000 Units) Forecast, By Region, 2017-2032
  • Table 11: North America Molecular Diagnostics in Infectious Disease Testing Market Value (US$ Mn) Forecast, By Country, 2017-2032
  • Table 12: North America Molecular Diagnostics in Infectious Disease Testing Market Volume ('000 Units) Forecast, By Country, 2017-2032
  • Table 13: North America Molecular Diagnostics in Infectious Disease Testing Market Value (US$ Mn) Forecast, By Product, 2017-2032
  • Table 14: North America Molecular Diagnostics in Infectious Disease Testing Market Volume ('000 Units) Forecast, By Product, 2017-2032
  • Table 15: North America Molecular Diagnostics in Infectious Disease Testing Market Value (US$ Mn) Forecast, By End User, 2017-2032
  • Table 16: North America Molecular Diagnostics in Infectious Disease Testing Market Volume ('000 Units) Forecast, By End User, 2017-2032
  • Table 17: North America Molecular Diagnostics in Infectious Disease Testing Market Value (US$ Mn) Forecast, By Application, 2017-2032
  • Table 18: North America Molecular Diagnostics in Infectious Disease Testing Market Volume ('000 Units) Forecast, By Application, 2017-2032
  • Table 19: North America Molecular Diagnostics in Infectious Disease Testing Market Value (US$ Mn) Forecast, By Technique, 2017-2032
  • Table 20: North America Molecular Diagnostics in Infectious Disease Testing Market Volume ('000 Units) Forecast, By Technique, 2017-2032
  • Table 21: Latin America Molecular Diagnostics in Infectious Disease Testing Market Value (US$ Mn) Forecast, By Country, 2017-2032
  • Table 22: Latin America Molecular Diagnostics in Infectious Disease Testing Market Volume ('000 Units) Forecast, By Country, 2017-2032
  • Table 23: Latin America Molecular Diagnostics in Infectious Disease Testing Market Value (US$ Mn) Forecast, By Product, 2017-2032
  • Table 24: Latin America Molecular Diagnostics in Infectious Disease Testing Market Volume ('000 Units) Forecast, By Product, 2017-2032
  • Table 25: Latin America Molecular Diagnostics in Infectious Disease Testing Market Value (US$ Mn) Forecast, By End User, 2017-2032
  • Table 26: Latin America Molecular Diagnostics in Infectious Disease Testing Market Volume ('000 Units) Forecast, By End User, 2017-2032
  • Table 27: Latin America Molecular Diagnostics in Infectious Disease Testing Market Value (US$ Mn) Forecast, By Application, 2017-2032
  • Table 28: Latin America Molecular Diagnostics in Infectious Disease Testing Market Volume ('000 Units) Forecast, By Application, 2017-2032
  • Table 29: Latin America Molecular Diagnostics in Infectious Disease Testing Market Value (US$ Mn) Forecast, By Technique, 2017-2032
  • Table 30: Latin America Molecular Diagnostics in Infectious Disease Testing Market Volume ('000 Units) Forecast, By Technique, 2017-2032
  • Table 31: Europe Molecular Diagnostics in Infectious Disease Testing Market Value (US$ Mn) Forecast, By Country, 2017-2032
  • Table 32: Europe Molecular Diagnostics in Infectious Disease Testing Market Volume ('000 Units) Forecast, By Country, 2017-2032
  • Table 33: Europe Molecular Diagnostics in Infectious Disease Testing Market Value (US$ Mn) Forecast, By Product, 2017-2032
  • Table 34: Europe Molecular Diagnostics in Infectious Disease Testing Market Volume ('000 Units) Forecast, By Product, 2017-2032
  • Table 35: Europe Molecular Diagnostics in Infectious Disease Testing Market Value (US$ Mn) Forecast, By End User, 2017-2032
  • Table 36: Europe Molecular Diagnostics in Infectious Disease Testing Market Volume ('000 Units) Forecast, By End User, 2017-2032
  • Table 37: Europe Molecular Diagnostics in Infectious Disease Testing Market Value (US$ Mn) Forecast, By Application, 2017-2032
  • Table 38: Europe Molecular Diagnostics in Infectious Disease Testing Market Volume ('000 Units) Forecast, By Application, 2017-2032
  • Table 39: Europe Molecular Diagnostics in Infectious Disease Testing Market Value (US$ Mn) Forecast, By Technique, 2017-2032
  • Table 40: Europe Molecular Diagnostics in Infectious Disease Testing Market Volume ('000 Units) Forecast, By Technique, 2017-2032
  • Table 41: East Asia Molecular Diagnostics in Infectious Disease Testing Market Value (US$ Mn) Forecast, By Country, 2017-2032
  • Table 42: East Asia Molecular Diagnostics in Infectious Disease Testing Market Volume ('000 Units) Forecast, By Country, 2017-2032
  • Table 43: East Asia Molecular Diagnostics in Infectious Disease Testing Market Value (US$ Mn) Forecast, By Product, 2017-2032
  • Table 44: East Asia Molecular Diagnostics in Infectious Disease Testing Market Volume ('000 Units) Forecast, By Product, 2017-2032
  • Table 45: East Asia Molecular Diagnostics in Infectious Disease Testing Market Value (US$ Mn) Forecast, By End User, 2017-2032
  • Table 46: East Asia Molecular Diagnostics in Infectious Disease Testing Market Volume ('000 Units) Forecast, By End User, 2017-2032
  • Table 47: East Asia Molecular Diagnostics in Infectious Disease Testing Market Value (US$ Mn) Forecast, By Application, 2017-2032
  • Table 48: East Asia Molecular Diagnostics in Infectious Disease Testing Market Volume ('000 Units) Forecast, By Application, 2017-2032
  • Table 49: East Asia Molecular Diagnostics in Infectious Disease Testing Market Value (US$ Mn) Forecast, By Technique, 2017-2032
  • Table 50: East Asia Molecular Diagnostics in Infectious Disease Testing Market Volume ('000 Units) Forecast, By Technique, 2017-2032
  • Table 51: South Asia Molecular Diagnostics in Infectious Disease Testing Market Value (US$ Mn) Forecast, By Country, 2017-2032
  • Table 52: South Asia Molecular Diagnostics in Infectious Disease Testing Market Volume ('000 Units) Forecast, By Country, 2017-2032
  • Table 53: South Asia Molecular Diagnostics in Infectious Disease Testing Market Value (US$ Mn) Forecast, By Product, 2017-2032
  • Table 54: South Asia Molecular Diagnostics in Infectious Disease Testing Market Volume ('000 Units) Forecast, By Product, 2017-2032
  • Table 55: South Asia Molecular Diagnostics in Infectious Disease Testing Market Value (US$ Mn) Forecast, By End User, 2017-2032
  • Table 56: South Asia Molecular Diagnostics in Infectious Disease Testing Market Volume ('000 Units) Forecast, By End User, 2017-2032
  • Table 57: South Asia Molecular Diagnostics in Infectious Disease Testing Market Value (US$ Mn) Forecast, By Application, 2017-2032
  • Table 58: South Asia Molecular Diagnostics in Infectious Disease Testing Market Volume ('000 Units) Forecast, By Application, 2017-2032
  • Table 59: South Asia Molecular Diagnostics in Infectious Disease Testing Market Value (US$ Mn) Forecast, By Technique, 2017-2032
  • Table 60: South Asia Molecular Diagnostics in Infectious Disease Testing Market Volume ('000 Units) Forecast, By Technique, 2017-2032
  • Table 61: Oceania Molecular Diagnostics in Infectious Disease Testing Market Value (US$ Mn) Forecast, By Country, 2017-2032
  • Table 62: Oceania Molecular Diagnostics in Infectious Disease Testing Market Volume ('000 Units) Forecast, By Country, 2017-2032
  • Table 63: Oceania Molecular Diagnostics in Infectious Disease Testing Market Value (US$ Mn) Forecast, By Product, 2017-2032
  • Table 64: Oceania Molecular Diagnostics in Infectious Disease Testing Market Volume ('000 Units) Forecast, By Product, 2017-2032
  • Table 65: Oceania Molecular Diagnostics in Infectious Disease Testing Market Value (US$ Mn) Forecast, By End User, 2017-2032
  • Table 66: Oceania Molecular Diagnostics in Infectious Disease Testing Market Volume ('000 Units) Forecast, By End User, 2017-2032
  • Table 67: Oceania Molecular Diagnostics in Infectious Disease Testing Market Value (US$ Mn) Forecast, By Application, 2017-2032
  • Table 68: Oceania Molecular Diagnostics in Infectious Disease Testing Market Volume ('000 Units) Forecast, By Application, 2017-2032
  • Table 69: Oceania Molecular Diagnostics in Infectious Disease Testing Market Value (US$ Mn) Forecast, By Technique, 2017-2032
  • Table 70: Oceania Molecular Diagnostics in Infectious Disease Testing Market Volume ('000 Units) Forecast, By Technique, 2017-2032
  • Table 71: MEA Molecular Diagnostics in Infectious Disease Testing Market Value (US$ Mn) Forecast, By Country, 2017-2032
  • Table 72: MEA Molecular Diagnostics in Infectious Disease Testing Market Volume ('000 Units) Forecast, By Country, 2017-2032
  • Table 73: MEA Molecular Diagnostics in Infectious Disease Testing Market Value (US$ Mn) Forecast, By Product, 2017-2032
  • Table 74: MEA Molecular Diagnostics in Infectious Disease Testing Market Volume ('000 Units) Forecast, By Product, 2017-2032
  • Table 75: MEA Molecular Diagnostics in Infectious Disease Testing Market Value (US$ Mn) Forecast, By End User, 2017-2032
  • Table 76: MEA Molecular Diagnostics in Infectious Disease Testing Market Volume ('000 Units) Forecast, By End User, 2017-2032
  • Table 77: MEA Molecular Diagnostics in Infectious Disease Testing Market Value (US$ Mn) Forecast, By Application, 2017-2032
  • Table 78: MEA Molecular Diagnostics in Infectious Disease Testing Market Volume ('000 Units) Forecast, By Application, 2017-2032
  • Table 79: MEA Molecular Diagnostics in Infectious Disease Testing Market Value (US$ Mn) Forecast, By Technique, 2017-2032
  • Table 80: MEA Molecular Diagnostics in Infectious Disease Testing Market Volume ('000 Units) Forecast, By Technique, 2017-2032

List of Figures

  • Figure 01: Global Molecular Diagnostics in Infectious Disease Testing Value (US$ Mn) and Volume ('000 Units) Analysis, 2017-2021
  • Figure 02: Global Molecular Diagnostics in Infectious Disease Testing Value (US$ Mn) and Volume ('000 Units) Forecast 2022-2032
  • Figure 03: Global Molecular Diagnostics in Infectious Disease Testing Value (US$ Mn) Analysis, 2017-2021
  • Figure 04: Global Molecular Diagnostics in Infectious Disease Testing Value (US$ Mn) Forecast, 2022-2032
  • Figure 05: Global Molecular Diagnostics in Infectious Disease Testing Absolute $ Opportunity (US$ Mn) 2022-2032
  • Figure 06: Global Molecular Diagnostics in Infectious Disease Testing Value (US$ Mn) Analysis by Product, 2017-2032
  • Figure 07: Global Molecular Diagnostics in Infectious Disease Testing Volume ('000 Units) Analysis by Product, 2017-2032
  • Figure 08: Global Molecular Diagnostics in Infectious Disease Testing Y-o-Y Growth (%) Projections, By Product, 2022-2032
  • Figure 09: Global Molecular Diagnostics in Infectious Disease Testing Attractiveness by Product, 2022-2032
  • Figure 10: Global Molecular Diagnostics in Infectious Disease Testing Value (US$ Mn) Analysis by End User, 2017-2032
  • Figure 11: Global Molecular Diagnostics in Infectious Disease Testing Volume ('000 Units) Analysis by End User, 2017-2032
  • Figure 12: Global Molecular Diagnostics in Infectious Disease Testing Y-o-Y Growth (%) Projections, By End User, 2022-2032
  • Figure 13: Global Molecular Diagnostics in Infectious Disease Testing Attractiveness by End User, 2022-2032
  • Figure 14: Global Molecular Diagnostics in Infectious Disease Testing Value (US$ Mn) Analysis by Application, 2017-2032
  • Figure 15: Global Molecular Diagnostics in Infectious Disease Testing Volume ('000 Units) Analysis by Application, 2017-2032
  • Figure 16: Global Molecular Diagnostics in Infectious Disease Testing Y-o-Y Growth (%) Projections, By Application, 2022-2032
  • Figure 17: Global Molecular Diagnostics in Infectious Disease Testing Attractiveness by Application, 2022-2032
  • Figure 18: Global Molecular Diagnostics in Infectious Disease Testing Value (US$ Mn) Analysis by Technique, 2017-2032
  • Figure 19: Global Molecular Diagnostics in Infectious Disease Testing Volume ('000 Units) Analysis by Technique, 2017-2032
  • Figure 20: Global Molecular Diagnostics in Infectious Disease Testing Y-o-Y Growth (%) Projections, By Technique, 2022-2032
  • Figure 21: Global Molecular Diagnostics in Infectious Disease Testing Attractiveness by Technique, 2022-2032
  • Figure 22: Global Molecular Diagnostics in Infectious Disease Testing Value (US$ Mn) Analysis by Region, 2017-2032
  • Figure 23: Global Molecular Diagnostics in Infectious Disease Testing Volume ('000 Units) Analysis by Region, 2017-2032
  • Figure 24: Global Molecular Diagnostics in Infectious Disease Testing Y-o-Y Growth (%) Projections, By Region, 2022-2032
  • Figure 25: Global Molecular Diagnostics in Infectious Disease Testing Attractiveness by Region, 2022-2032
  • Figure 26: North America Molecular Diagnostics in Infectious Disease Testing Value (US$ Mn) Analysis by Country, 2017-2032
  • Figure 27: North America Molecular Diagnostics in Infectious Disease Testing Volume ('000 Units) Analysis by Country, 2017-2032
  • Figure 28: North America Molecular Diagnostics in Infectious Disease Testing Y-o-Y Growth (%) Projections, By Country, 2022-2032
  • Figure 29: North America Molecular Diagnostics in Infectious Disease Testing Attractiveness by Country, 2022-2032
  • Figure 30: North America Molecular Diagnostics in Infectious Disease Testing Value (US$ Mn) Analysis by Product, 2017-2032
  • Figure 31: North America Molecular Diagnostics in Infectious Disease Testing Volume ('000 Units) Analysis by Product, 2017-2032
  • Figure 32: North America Molecular Diagnostics in Infectious Disease Testing Y-o-Y Growth (%) Projections, By Product, 2022-2032
  • Figure 33: North America Molecular Diagnostics in Infectious Disease Testing Attractiveness by Product, 2022-2032
  • Figure 34: North America Molecular Diagnostics in Infectious Disease Testing Value (US$ Mn) Analysis by End User, 2017-2032
  • Figure 35: North America Molecular Diagnostics in Infectious Disease Testing Volume ('000 Units) Analysis by End User, 2017-2032
  • Figure 36: North America Molecular Diagnostics in Infectious Disease Testing Y-o-Y Growth (%) Projections, By End User, 2022-2032
  • Figure 37: North America Molecular Diagnostics in Infectious Disease Testing Attractiveness by End User, 2022-2032
  • Figure 38: North America Molecular Diagnostics in Infectious Disease Testing Value (US$ Mn) Analysis by Application, 2017-2032
  • Figure 39: North America Molecular Diagnostics in Infectious Disease Testing Volume ('000 Units) Analysis by Application, 2017-2032
  • Figure 40: North America Molecular Diagnostics in Infectious Disease Testing Y-o-Y Growth (%) Projections, By Application, 2022-2032
  • Figure 41: North America Molecular Diagnostics in Infectious Disease Testing Attractiveness by Application, 2022-2032
  • Figure 42: North America Molecular Diagnostics in Infectious Disease Testing Value (US$ Mn) Analysis by Technique, 2017-2032
  • Figure 43: North America Molecular Diagnostics in Infectious Disease Testing Volume ('000 Units) Analysis by Technique, 2017-2032
  • Figure 44: North America Molecular Diagnostics in Infectious Disease Testing Y-o-Y Growth (%) Projections, By Technique, 2022-2032
  • Figure 45: North America Molecular Diagnostics in Infectious Disease Testing Attractiveness by Technique, 2022-2032
  • Figure 46: Latin America Molecular Diagnostics in Infectious Disease Testing Value (US$ Mn) Analysis by Country, 2017-2032
  • Figure 47: Latin America Molecular Diagnostics in Infectious Disease Testing Volume ('000 Units) Analysis by Country, 2017-2032
  • Figure 48: Latin America Molecular Diagnostics in Infectious Disease Testing Y-o-Y Growth (%) Projections, By Country, 2022-2032
  • Figure 49: Latin America Molecular Diagnostics in Infectious Disease Testing Attractiveness by Country, 2022-2032
  • Figure 50: Latin America Molecular Diagnostics in Infectious Disease Testing Value (US$ Mn) Analysis by Product, 2017-2032
  • Figure 51: Latin America Molecular Diagnostics in Infectious Disease Testing Volume ('000 Units) Analysis by Product, 2017-2032
  • Figure 52: Latin America Molecular Diagnostics in Infectious Disease Testing Y-o-Y Growth (%) Projections, By Product, 2022-2032
  • Figure 53: Latin America Molecular Diagnostics in Infectious Disease Testing Attractiveness by Product, 2022-2032
  • Figure 54: Latin America Molecular Diagnostics in Infectious Disease Testing Value (US$ Mn) Analysis by End User, 2017-2032
  • Figure 55: Latin America Molecular Diagnostics in Infectious Disease Testing Volume ('000 Units) Analysis by End User, 2017-2032
  • Figure 56: Latin America Molecular Diagnostics in Infectious Disease Testing Y-o-Y Growth (%) Projections, By End User, 2022-2032
  • Figure 57: Latin America Molecular Diagnostics in Infectious Disease Testing Attractiveness by End User, 2022-2032
  • Figure 58: North America Molecular Diagnostics in Infectious Disease Testing Value (US$ Mn) Analysis by Technique, 2017-2032
  • Figure 59: North America Molecular Diagnostics in Infectious Disease Testing Volume ('000 Units) Analysis by Technique, 2017-2032
  • Figure 60: North America Molecular Diagnostics in Infectious Disease Testing Y-o-Y Growth (%) Projections, By Technique, 2022-2032
  • Figure 61: North America Molecular Diagnostics in Infectious Disease Testing Attractiveness by Technique, 2022-2032
  • Figure 62: Latin America Molecular Diagnostics in Infectious Disease Testing Value (US$ Mn) Analysis by Country, 2017-2032
  • Figure 63: Latin America Molecular Diagnostics in Infectious Disease Testing Volume ('000 Units) Analysis by Technique, 2017-2032
  • Figure 64: Latin America Molecular Diagnostics in Infectious Disease Testing Y-o-Y Growth (%) Projections, By Technique, 2022-2032
  • Figure 65: Latin America Molecular Diagnostics in Infectious Disease Testing Attractiveness by Technique, 2022-2032
  • Figure 66: Europe Molecular Diagnostics in Infectious Disease Testing Value (US$ Mn) Analysis by Country, 2017-2032
  • Figure 67: Europe Molecular Diagnostics in Infectious Disease Testing Volume ('000 Units) Analysis by Country, 2017-2032
  • Figure 68: Europe Molecular Diagnostics in Infectious Disease Testing Y-o-Y Growth (%) Projections, By Country, 2022-2032
  • Figure 69: Europe Molecular Diagnostics in Infectious Disease Testing Attractiveness by Country, 2022-2032
  • Figure 70: Europe Molecular Diagnostics in Infectious Disease Testing Value (US$ Mn) Analysis by Product, 2017-2032
  • Figure 71: Europe Molecular Diagnostics in Infectious Disease Testing Volume ('000 Units) Analysis by Product, 2017-2032
  • Figure 72: Europe Molecular Diagnostics in Infectious Disease Testing Y-o-Y Growth (%) Projections, By Product, 2022-2032
  • Figure 73: Europe Molecular Diagnostics in Infectious Disease Testing Attractiveness by Product, 2022-2032
  • Figure 74: Europe Molecular Diagnostics in Infectious Disease Testing Value (US$ Mn) Analysis by End User, 2017-2032
  • Figure 75: Europe Molecular Diagnostics in Infectious Disease Testing Volume ('000 Units) Analysis by End User, 2017-2032
  • Figure 76: Europe Molecular Diagnostics in Infectious Disease Testing Y-o-Y Growth (%) Projections, By End User, 2022-2032
  • Figure 77: Europe Molecular Diagnostics in Infectious Disease Testing Attractiveness by End User, 2022-2032
  • Figure 78: Europe Molecular Diagnostics in Infectious Disease Testing Value (US$ Mn) Analysis by Application, 2017-2032
  • Figure 79: Europe Molecular Diagnostics in Infectious Disease Testing Volume ('000 Units) Analysis by Application, 2017-2032
  • Figure 80: Europe Molecular Diagnostics in Infectious Disease Testing Y-o-Y Growth (%) Projections, By Application, 2022-2032
  • Figure 81: Europe Molecular Diagnostics in Infectious Disease Testing Attractiveness by Application, 2022-2032
  • Figure 82: Europe Molecular Diagnostics in Infectious Disease Testing Value (US$ Mn) Analysis by Technique, 2017-2032
  • Figure 83: Europe Molecular Diagnostics in Infectious Disease Testing Volume ('000 Units) Analysis by Technique, 2017-2032
  • Figure 84: Europe Molecular Diagnostics in Infectious Disease Testing Y-o-Y Growth (%) Projections, By Technique, 2022-2032
  • Figure 85: Europe Molecular Diagnostics in Infectious Disease Testing Attractiveness by Technique, 2022-2032
  • Figure 86: East Asia Molecular Diagnostics in Infectious Disease Testing Value (US$ Mn) Analysis by Country, 2017-2032
  • Figure 87: East Asia Molecular Diagnostics in Infectious Disease Testing Volume ('000 Units) Analysis by Country, 2017-2032
  • Figure 88: East Asia Molecular Diagnostics in Infectious Disease Testing Y-o-Y Growth (%) Projections, By Country, 2022-2032
  • Figure 89: East Asia Molecular Diagnostics in Infectious Disease Testing Attractiveness by Country, 2022-2032
  • Figure 90: East Asia Molecular Diagnostics in Infectious Disease Testing Value (US$ Mn) Analysis by Product, 2017-2032
  • Figure 91: East Asia Molecular Diagnostics in Infectious Disease Testing Volume ('000 Units) Analysis by Product, 2017-2032
  • Figure 92: East Asia Molecular Diagnostics in Infectious Disease Testing Y-o-Y Growth (%) Projections, By Product, 2022-2032
  • Figure 93: East Asia Molecular Diagnostics in Infectious Disease Testing Attractiveness by Product, 2022-2032
  • Figure 94: East Asia Molecular Diagnostics in Infectious Disease Testing Value (US$ Mn) Analysis by End User, 2017-2032
  • Figure 95: East Asia Molecular Diagnostics in Infectious Disease Testing Volume ('000 Units) Analysis by End User, 2017-2032
  • Figure 96: East Asia Molecular Diagnostics in Infectious Disease Testing Y-o-Y Growth (%) Projections, By End User, 2022-2032
  • Figure 97: East Asia Molecular Diagnostics in Infectious Disease Testing Attractiveness by End User, 2022-2032
  • Figure 98: East Asia Molecular Diagnostics in Infectious Disease Testing Value (US$ Mn) Analysis by Application, 2017-2032
  • Figure 99: East Asia Molecular Diagnostics in Infectious Disease Testing Volume ('000 Units) Analysis by Application, 2017-2032
  • Figure 100: East Asia Molecular Diagnostics in Infectious Disease Testing Y-o-Y Growth (%) Projections, By Application, 2022-2032
  • Figure 101: East Asia Molecular Diagnostics in Infectious Disease Testing Attractiveness by Application, 2022-2032
  • Figure 102: East Asia Molecular Diagnostics in Infectious Disease Testing Value (US$ Mn) Analysis by Technique, 2017-2032
  • Figure 103: East Asia Molecular Diagnostics in Infectious Disease Testing Volume ('000 Units) Analysis by Technique, 2017-2032
  • Figure 104: East Asia Molecular Diagnostics in Infectious Disease Testing Y-o-Y Growth (%) Projections, By Technique, 2022-2032
  • Figure 105: East Asia Molecular Diagnostics in Infectious Disease Testing Attractiveness by Technique, 2022-2032
  • Figure 106: South Asia Molecular Diagnostics in Infectious Disease Testing Value (US$ Mn) Analysis by Country, 2017-2032
  • Figure 107: South Asia Molecular Diagnostics in Infectious Disease Testing Volume ('000 Units) Analysis by Country, 2017-2032
  • Figure 108: South Asia Molecular Diagnostics in Infectious Disease Testing Y-o-Y Growth (%) Projections, By Country, 2022-2032
  • Figure 109: South Asia Molecular Diagnostics in Infectious Disease Testing Attractiveness by Country, 2022-2032
  • Figure 110: South Asia Molecular Diagnostics in Infectious Disease Testing Value (US$ Mn) Analysis by Product, 2017-2032
  • Figure 111: South Asia Molecular Diagnostics in Infectious Disease Testing Volume ('000 Units) Analysis by Product, 2017-2032
  • Figure 112: South Asia Molecular Diagnostics in Infectious Disease Testing Y-o-Y Growth (%) Projections, By Product, 2022-2032
  • Figure 113: South Asia Molecular Diagnostics in Infectious Disease Testing Attractiveness by Product, 2022-2032
  • Figure 114: South Asia Molecular Diagnostics in Infectious Disease Testing Value (US$ Mn) Analysis by End User, 2017-2032
  • Figure 115: South Asia Molecular Diagnostics in Infectious Disease Testing Volume ('000 Units) Analysis by End User, 2017-2032
  • Figure 116: South Asia Molecular Diagnostics in Infectious Disease Testing Y-o-Y Growth (%) Projections, By End User, 2022-2032
  • Figure 117: South Asia Molecular Diagnostics in Infectious Disease Testing Attractiveness by End User, 2022-2032
  • Figure 118: South Asia Molecular Diagnostics in Infectious Disease Testing Value (US$ Mn) Analysis by Application, 2017-2032
  • Figure 119: South Asia Molecular Diagnostics in Infectious Disease Testing Volume ('000 Units) Analysis by Application, 2017-2032
  • Figure 120: South Asia Molecular Diagnostics in Infectious Disease Testing Y-o-Y Growth (%) Projections, By Application, 2022-2032
  • Figure 121: South Asia Molecular Diagnostics in Infectious Disease Testing Attractiveness by Application, 2022-2032
  • Figure 122: South Asia Molecular Diagnostics in Infectious Disease Testing Value (US$ Mn) Analysis by Technique, 2017-2032
  • Figure 123: South Asia Molecular Diagnostics in Infectious Disease Testing Volume ('000 Units) Analysis by Technique, 2017-2032
  • Figure 124: South Asia Molecular Diagnostics in Infectious Disease Testing Y-o-Y Growth (%) Projections, By Technique, 2022-2032
  • Figure 125: South Asia Molecular Diagnostics in Infectious Disease Testing Attractiveness by Technique, 2022-2032
  • Figure 126: Oceania Molecular Diagnostics in Infectious Disease Testing Value (US$ Mn) Analysis by Country, 2017-2032
  • Figure 127: Oceania Molecular Diagnostics in Infectious Disease Testing Volume ('000 Units) Analysis by Country, 2017-2032
  • Figure 128: Oceania Molecular Diagnostics in Infectious Disease Testing Y-o-Y Growth (%) Projections, By Country, 2022-2032
  • Figure 129: Oceania Molecular Diagnostics in Infectious Disease Testing Attractiveness by Country, 2022-2032
  • Figure 130: Oceania Molecular Diagnostics in Infectious Disease Testing Value (US$ Mn) Analysis by Product, 2017-2032
  • Figure 131: Oceania Molecular Diagnostics in Infectious Disease Testing Volume ('000 Units) Analysis by Product, 2017-2032
  • Figure 132: Oceania Molecular Diagnostics in Infectious Disease Testing Y-o-Y Growth (%) Projections, By Product, 2022-2032
  • Figure 133: Oceania Molecular Diagnostics in Infectious Disease Testing Attractiveness by Product, 2022-2032
  • Figure 134: Oceania Molecular Diagnostics in Infectious Disease Testing Value (US$ Mn) Analysis by End User, 2017-2032
  • Figure 135: Oceania Molecular Diagnostics in Infectious Disease Testing Volume ('000 Units) Analysis by End User, 2017-2032
  • Figure 136: Oceania Molecular Diagnostics in Infectious Disease Testing Y-o-Y Growth (%) Projections, By End User, 2022-2032
  • Figure 137: Oceania Molecular Diagnostics in Infectious Disease Testing Attractiveness by End User, 2022-2032
  • Figure 138: Oceania Molecular Diagnostics in Infectious Disease Testing Value (US$ Mn) Analysis by Application, 2017-2032
  • Figure 139: Oceania Molecular Diagnostics in Infectious Disease Testing Volume ('000 Units) Analysis by Application, 2017-2032
  • Figure 140: Oceania Molecular Diagnostics in Infectious Disease Testing Y-o-Y Growth (%) Projections, By Application, 2022-2032
  • Figure 141: Oceania Molecular Diagnostics in Infectious Disease Testing Attractiveness by Application, 2022-2032
  • Figure 142: Oceania Molecular Diagnostics in Infectious Disease Testing Value (US$ Mn) Analysis by Technique, 2017-2032
  • Figure 143: Oceania Molecular Diagnostics in Infectious Disease Testing Volume ('000 Units) Analysis by Technique, 2017-2032
  • Figure 144: Oceania Molecular Diagnostics in Infectious Disease Testing Y-o-Y Growth (%) Projections, By Technique, 2022-2032
  • Figure 145: Oceania Molecular Diagnostics in Infectious Disease Testing Attractiveness by Technique, 2022-2032
  • Figure 146: MEA Molecular Diagnostics in Infectious Disease Testing Value (US$ Mn) Analysis by Country, 2017-2032
  • Figure 147: MEA Molecular Diagnostics in Infectious Disease Testing Volume ('000 Units) Analysis by Country, 2017-2032
  • Figure 148: MEA Molecular Diagnostics in Infectious Disease Testing Y-o-Y Growth (%) Projections, By Country, 2022-2032
  • Figure 149: MEA Molecular Diagnostics in Infectious Disease Testing Attractiveness by Country, 2022-2032
  • Figure 150: MEA Molecular Diagnostics in Infectious Disease Testing Value (US$ Mn) Analysis by Product, 2017-2032
  • Figure 151: MEA Molecular Diagnostics in Infectious Disease Testing Volume ('000 Units) Analysis by Product, 2017-2032
  • Figure 152: MEA Molecular Diagnostics in Infectious Disease Testing Y-o-Y Growth (%) Projections, By Product, 2022-2032
  • Figure 153: MEA Molecular Diagnostics in Infectious Disease Testing Attractiveness by Product, 2022-2032
  • Figure 154: MEA Molecular Diagnostics in Infectious Disease Testing Value (US$ Mn) Analysis by End User, 2017-2032
  • Figure 155: MEA Molecular Diagnostics in Infectious Disease Testing Volume ('000 Units) Analysis by End User, 2017-2032
  • Figure 156: MEA Molecular Diagnostics in Infectious Disease Testing Y-o-Y Growth (%) Projections, By End User, 2022-2032
  • Figure 157: MEA Molecular Diagnostics in Infectious Disease Testing Attractiveness by End User, 2022-2032
  • Figure 158: MEA Molecular Diagnostics in Infectious Disease Testing Value (US$ Mn) Analysis by Application, 2017-2032
  • Figure 159: MEA Molecular Diagnostics in Infectious Disease Testing Volume ('000 Units) Analysis by Application, 2017-2032
  • Figure 160: MEA Molecular Diagnostics in Infectious Disease Testing Y-o-Y Growth (%) Projections, By Application, 2022-2032
  • Figure 161: MEA Molecular Diagnostics in Infectious Disease Testing Attractiveness by Application, 2022-2032
  • Figure 162: MEA Molecular Diagnostics in Infectious Disease Testing Value (US$ Mn) Analysis by Technique, 2017-2032
  • Figure 163: MEA Molecular Diagnostics in Infectious Disease Testing Volume ('000 Units) Analysis by Technique, 2017-2032
  • Figure 164: MEA Molecular Diagnostics in Infectious Disease Testing Y-o-Y Growth (%) Projections, By Technique, 2022-2032
  • Figure 165: MEA Molecular Diagnostics in Infectious Disease Testing Attractiveness by Technique, 2022-2032